{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:52:54Z","timestamp":1761630774895},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","nutritionjrnl.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.nut.2016.12.022","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T18:18:12Z","timestamp":1484072292000},"page":"28-33","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The Polish Intestinal Failure Centres\u2019 consensus on the use of teduglutide for the treatment of short bowel syndrome"],"prefix":"10.1016","volume":"38","author":[{"given":"Stanis\u0142aw","family":"Klek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Kunecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Sobocki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Matysiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Karwowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystyna","family":"Urbanowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2016.12.022_bib1","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/gut.2010.218271","article-title":"Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and\/or intravenous fluid requirements in patients with short bowel syndrome","volume":"60","author":"Jeppesen","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.nut.2016.12.022_bib2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2016.12.022_bib3","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1073\/pnas.93.15.7911","article-title":"Induction of intestinal epithelial proliferation by glucagon- like peptide 2","volume":"93","author":"Drucker","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nut.2016.12.022_bib4","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jcem.84.7.5840","article-title":"Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2","volume":"84","author":"Wojdemann","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nut.2016.12.022_bib5","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1080\/00365529850171486","article-title":"Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs","volume":"33","author":"Wojdemann","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.nut.2016.12.022_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2005.11.005","article-title":"GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow","volume":"130","author":"Guan","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2016.12.022_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00365520802538195","article-title":"Glucagon-like peptide-2 increases mesenteric blood flow in humans","volume":"44","author":"Bremholm","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.nut.2016.12.022_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gut.47.1.112","article-title":"Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both\u00a0transcellular and paracellular pathways in the mouse","volume":"47","author":"Benjamin","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.nut.2016.12.022_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.nut.2016.12.022_bib10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/gast.2001.22555","article-title":"Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon","volume":"120","author":"Jeppesen","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2016.12.022_bib11","first-page":"E1050","article-title":"Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2","volume":"272","author":"Brubaker","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.nut.2016.12.022_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/1756283X11436318","article-title":"Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome","volume":"5","author":"Jeppesen","year":"2012","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.nut.2016.12.022_bib13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cgh.2012.12.029","article-title":"Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel syndrome-intestinal failure","volume":"11","author":"O\u2019Keefe","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.nut.2016.12.022_bib14","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/ctg.2015.69","article-title":"Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome","volume":"4","author":"Schwartz","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.nut.2016.12.022_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0016-5085(13)60604-6","article-title":"Complete enteral autonomy and independence from parenteral nutrition\/intravenous support in short bowel syndrome with intestinal failure\u2014accruing experience with teduglutide","volume":"144","author":"Iyer","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2016.12.022_bib16","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1016\/S0016-5085(12)61395-X","article-title":"Short bowel syndrome\u00a0patients with intestinal failure (SBS-IF) successfully achieved complete\u00a0independence from parenteral nutrition and\/or intravenous fluid (PN\/IV) with teduglutide","volume":"142","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2016.12.022_bib17","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.14309\/00000434-201210001-00330","article-title":"Long term therapy with teduglutide: Characteristics of patients with short bowel syndrome who achieve complete independence from parenteral nutrition and\/or intravenous fluid support","volume":"107","author":"Fujioka","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.nut.2016.12.022_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0148607112472906","article-title":"Increased intestinal absorption in the era of teduglutide and its impact on management strategies in associated intestinal failure -patients with short bowel syndrome","volume":"37","author":"Seidner","year":"2013","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.nut.2016.12.022_bib19","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/S0261-5614(14)50437-2","article-title":"Long-term safety and efficacy with teduglutide treatment in patients with intestinal failure associated with short bowel syndrome (SBS\u2013IF): the STEPS-3 study","volume":"33","author":"Iyer","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2016.12.022_bib20","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S0261-5614(14)50173-2","article-title":"Independence from parenteral support achieved with teduglutide treatment in patients with intestinal failure associated with short bowel syndrome","volume":"33","author":"Jeppessen","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2016.12.022_bib21","series-title":"Basics in clinical nutrition","author":"Sobotka","year":"2012"},{"key":"10.1016\/j.nut.2016.12.022_bib22","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.2000.20227","article-title":"Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans","volume":"119","author":"Crenn","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nut.2016.12.022_bib23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/MCO.0b013e32829fb38d","article-title":"Citrulline and the gut","volume":"10","author":"Curis","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.nut.2016.12.022_bib24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.clnu.2009.04.001","article-title":"ESPEN Guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients","volume":"28","author":"Staun","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nut.2016.12.022_bib25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2004.061440","article-title":"Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients","volume":"54","author":"Jeppesen","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.nut.2016.12.022_bib26","unstructured":"Shire. Revestive \u2013 Product Characteristics. https:\/\/www.medicines.org.uk\/emc\/medicine\/29315. Accessed January 24,\u00a02017."},{"key":"10.1016\/j.nut.2016.12.022_bib27","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/0148607115594010","article-title":"Clinical management of patients with parenteral nutrition-dependent short bowel syndrome during teduglutide therapy","volume":"40","author":"Compher","year":"2016","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.nut.2016.12.022_bib28","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.clnu.2016.04.009","article-title":"Management of acute intestinal failure: a position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group","volume":"35","author":"Klek","year":"2016","journal-title":"Clin Nutr"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900717300060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900717300060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T20:43:57Z","timestamp":1601325837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900717300060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":28,"alternative-id":["S0899900717300060"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2016.12.022","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Polish Intestinal Failure Centres\u2019 consensus on the use of teduglutide for the treatment of short bowel syndrome","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2016.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}